Cel-Sci
CVM
#10153
Rank
A$42.58 M
Marketcap
A$5.04
Share price
1.17%
Change (1 day)
-54.32%
Change (1 year)

Earnings for Cel-Sci (CVM)

Earnings in 2025 (TTM): -A$38.73 Million

According to Cel-Sci 's latest financial reports the company's current earnings are N/A. In 2024 the company made an earning of -A$38.56 Million, an increase over its 2023 earnings that were of -A$44.02 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Cel-Sci from 1986 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -A$38.73 Million0.46%
2024 -A$38.56 Million-12.41%
2023 -A$44.02 Million-12.87%
2022 -A$50.52 Million-3.42%
2021 -A$52.31 Million13.44%
2020 -A$46.11 Million11.28%
2019 -A$41.44 Million179.81%
2018 -A$14.81 Million-48.72%
2017 -A$28.88 Million-16.23%
2016 -A$34.48 Million-23.63%
2015 -A$45.14 Million-5.47%
2014 -A$47.76 Million198.49%
2013 -A$16 Million
2010 -A$18.68 Million
2004 -A$6.32 Million12.38%
2003 -A$5.62 Million-16.59%
2002 -A$6.74 Million-59.28%
2001 -A$16.54 Million23.17%
2000 -A$13.43 Million20.12%
1999 -A$11.18 Million13.24%
1998 -A$9.87 Million-20%
1997 -A$12.34 Million46.55%
1996 -A$8.42 Million34.88%
1995 -A$6.24 Million2.38%
1994 -A$6.1 Million68%
1993 -A$3.63 Million78.57%
1992 -A$2.04 Million180%
1991 -A$0.73 Million25%
1990 -A$0.59 Million-0%
1989 -A$0.59 Million-71.43%
1988 -A$2.04 Million-0%
1987 -A$2.04 Million-46.15%
1986 -A$3.78 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
A$48.68 B-135,597.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
A$13.02 B-36,348.94%๐Ÿ‡บ๐Ÿ‡ธ USA
Xencor
XNCR
-A$0.21 Billion 457.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Curis
CRIS
-A$47.25 Million 31.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
A$3.12 B-8,790.70%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
BioCryst Pharmaceuticals
BCRX
A$0.38 B-1,179.84%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
A$0.23 B-767.55%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
-A$13.77 Million-61.68%๐Ÿ‡บ๐Ÿ‡ธ USA